Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV

  1. Dueñas-Gutiérrez, C.
  2. Buzón, L.
  3. Pedrero-Tomé, R.
  4. Iribarren, J.A.
  5. De los Santos, I.
  6. De la Fuente, S.
  7. Pousada, G.
  8. Moran, M.A.
  9. Moreno, E.
  10. Ferreira, E.
  11. Gómez, J.
  12. Troya, J.
Revue:
Viruses

ISSN: 1999-4915

Année de publication: 2023

Volumen: 15

Número: 4

Type: Article

DOI: 10.3390/V15040936 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable